ProfileGDS4718 / 215859_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 18% 21% 16% 23% 19% 17% 18% 26% 35% 27% 26% 16% 17% 19% 20% 24% 27% 22% 21% 15% 25% 24% 27% 19% 21% 16% 20% 19% 23% 14% 21% 16% 20% 22% 20% 19% 19% 21% 24% 23% 28% 21% 18% 20% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0768218
GSM549102patient 115, normal, homogenized [OPG study]4.1804421
GSM549104patient 119, normal, homogenized [OPG study]3.963316
GSM549108patient 138, normal, homogenized [OPG study]4.3098923
GSM549119patient 077, normal, homogenized [OPG study]4.0912319
GSM549133patient 032, cancer, homogenized [OPG study]4.0064517
GSM549139patient 042, cancer, homogenized [OPG study]4.064718
GSM549099patient 107, normal, homogenized [OPG study]4.3873226
GSM549109patient 139, normal, homogenized [OPG study]4.764735
GSM549110patient 046, normal, homogenized [OPG study]4.4317327
GSM549114patient 063, normal, homogenized [OPG study]4.3476626
GSM549122patient 082, normal, homogenized [OPG study]3.9929116
GSM549134patient 033, cancer, homogenized [OPG study]4.0405117
GSM549136patient 036, cancer, homogenized [OPG study]4.0655119
GSM549140patient 044, cancer, homogenized [OPG study]4.095620
GSM549111patient 047, normal, homogenized [OPG study]4.2595424
GSM549113patient 057, normal, homogenized [OPG study]4.3835327
GSM549132patient 031, cancer, homogenized [OPG study]4.2027122
GSM549137patient 038, cancer, homogenized [OPG study]4.1796621
GSM549142patient 047, cancer, homogenized [OPG study]4.0249115
GSM549100patient 110, normal, homogenized [OPG study]4.3723425
GSM549107patient 135, normal, homogenized [OPG study]4.2721124
GSM549115patient 068, normal, homogenized [OPG study]4.3684427
GSM549116patient 072, normal, homogenized [OPG study]4.1057919
GSM549120patient 078, normal, homogenized [OPG study]4.1664121
GSM549131patient 030, cancer, homogenized [OPG study]3.9439516
GSM549118patient 074, normal, homogenized [OPG study]4.1617720
GSM549129patient 027, cancer, homogenized [OPG study]4.1141619
GSM549123patient 088, normal, homogenized [OPG study]4.2555423
GSM549124patient 006, cancer, homogenized [OPG study]3.9673914
GSM549126patient 015, cancer, homogenized [OPG study]4.1892321
GSM549128patient 025, cancer, homogenized [OPG study]3.9799816
GSM549103patient 117, normal, homogenized [OPG study]4.1991720
GSM549117patient 073, normal, homogenized [OPG study]4.2008722
GSM549138patient 041, cancer, homogenized [OPG study]4.1152320
GSM549141patient 045, cancer, homogenized [OPG study]4.0368219
GSM549130patient 028, cancer, homogenized [OPG study]4.1253419
GSM549101patient 111, normal, homogenized [OPG study]4.1966921
GSM549105patient 128, normal, homogenized [OPG study]4.3113524
GSM549106patient 134, normal, homogenized [OPG study]4.2013923
GSM549112patient 048, normal, homogenized [OPG study]4.4712228
GSM549125patient 011, cancer, homogenized [OPG study]4.185121
GSM549127patient 024, cancer, homogenized [OPG study]4.0389718
GSM549135patient 035, cancer, homogenized [OPG study]4.0842320